Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-2.4%
5Y CAGR+96.6%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-2.4%/yr
Annual compound
5Y CAGR
+96.6%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
29.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$13.94M+393.8%
2024$2.82M-61.8%
2023$7.39M-50.7%
2022$14.98M+73.7%
2021$8.62M+1716.1%
2020$474809.00+101.1%
2019$236151.00-